NCT07703592

Brief Summary

The pulmonary artery catheter (Swan-Ganz) is a standard tool in intensive care for measuring and monitoring the pulmonary artery occlusion pressure (PAOP). The Swan-Ganz IQ™ model also allows automatic measurement to reduce the risk of error (Smart Wedge). However, the concordance between this automatic method and the manual method remains poorly studied in real clinical conditions and may vary depending on certain clinical situations. This study therefore aims to compare the PAOP automatically measured (Smart Wedge) with the manual PAOP measurement at bedside based on data collected in clinical practice.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
23mo left

Started Jul 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Jul 2026Jul 2028

First Submitted

Initial submission to the registry

July 8, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

July 10, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 14, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2028

Last Updated

July 17, 2026

Status Verified

June 1, 2026

Enrollment Period

2 years

First QC Date

July 8, 2026

Last Update Submit

July 16, 2026

Conditions

Keywords

Swan-ganz IQ™Swan-Ganzpulmonary artery occlusion preassure

Outcome Measures

Primary Outcomes (1)

  • Assess the agreement between PAOP values measured by the "Smart Wedge" algorithm and PAOP values analyzed by an expert in patients in shock who are being monitored via a pulmonary artery catheter (Swan Ganz IQ)

    The concordance between manual PAOP and automatic PAOP (assessed by the SmartWedge algorithm during the inflation of the ballon in the arterial pulmonary).

    1 day

Secondary Outcomes (3)

  • Identify situations where there is a risk of discrepancy in the "Smart Wedge" value

    1 day

  • Assess the variability between PAOP values measured by the Smart Wedge algorithm and those measured by an expert.

    1 day

  • Assess the agreement between the PAPO value provided by the "Smart Wedge" algorithm and the PAPO value used in clinical practice, and compare it to the agreement observed between the algorithm and the expert interpretation performed retrospectively.

    1 day

Interventions

Swan-Ganz IQ™ is a device that provides continuous measurement of cardiac index by analyzing the right ventricular pressure wave. The "Smart Wedge" module provides an automated estimate of PAPO as well as a signal quality indicator ("wedge index"), designed to assess the reliability of the measurement and alert the operator in the event of an unusable signal. This algorithm underwent regulatory validation based on retrospective data compared to an expert interpretation of selected tracings, leading to its approval for clinical use.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients hospitalized in medical ICU (of Bicêtre and Angers) with pulmonary arterial catheter (PAC) place as part of routine clinical care.

You may qualify if:

  • Age ≥18 years;
  • Admission to an intensive care unit;
  • Presence of a Swan-Ganz IQ™ pulmonary artery catheter placed as part of patient care;
  • Measurement of pulmonary artery occlusion pressure (PAOP) performed by the attending clinician as part of patient care.

You may not qualify if:

  • Pregnancy;
  • Court-ordered protective measures.
  • Refusal to participate by the patient's family members or the patient themselves.
  • Cardiac output measurements by thermodilution or by continuous cardiac output analysis that cannot be interpreted.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Shock, Septic

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Officials

  • Xavier MONNET

    Assistance Publique - Hôpitaux de Paris

    STUDY DIRECTOR

Central Study Contacts

Nicolas FAGE

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2026

First Posted

July 14, 2026

Study Start

July 10, 2026

Primary Completion (Estimated)

July 10, 2028

Study Completion (Estimated)

July 10, 2028

Last Updated

July 17, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share